NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells

Hyperglycemia, obesity and metabolic syndrome are negative prognostic factors in breast cancer patients. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, achieving unprecedented efficacy in multiple malignancies. However, ICIs are associated with immune-related adverse event...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Mol Sci
Hlavní autoři: Quagliariello, Vincenzo, De Laurentiis, Michelino, Cocco, Stefania, Rea, Giuseppina, Bonelli, Annamaria, Caronna, Antonietta, Lombari, Maria Cristina, Conforti, Gabriele, Berretta, Massimiliano, Botti, Gerardo, Maurea, Nicola
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7589802/
https://ncbi.nlm.nih.gov/pubmed/33096896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21207802
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky